Robert Susman's most recent trade in Immunovant Inc was a trade of 35,234 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunovant Inc | Robert Susman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 35,234 | 35,234 | - | - | Stock Option (Right to Buy) | |
| Immunovant Inc | Robert Susman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 25,016 | 25,016 (0%) | 0% | 0 | Common Stock |